Success Metrics

Clinical Success Rate
75.0%

Based on 3 completed trials

Completion Rate
75%(3/4)
Active Trials
0(0%)
Results Posted
33%(1 trials)
Terminated
1(20%)

Phase Distribution

Ph phase_1
3
60%
Ph phase_2
2
40%

Phase Distribution

3

Early Stage

2

Mid Stage

0

Late Stage

Phase Distribution5 total trials
Phase 1Safety & dosage
3(60.0%)
Phase 2Efficacy & side effects
2(40.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

60.0%

3 of 5 finished

Non-Completion Rate

40.0%

2 ended early

Currently Active

0

trials recruiting

Total Trials

5

all time

Status Distribution
Completed(3)
Terminated(2)

Detailed Status

Completed3
Terminated1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
0
Success Rate
75.0%
Most Advanced
Phase 2

Trials by Phase

Phase 13 (60.0%)
Phase 22 (40.0%)

Trials by Status

completed360%
terminated120%
withdrawn120%

Recent Activity

0 active trials
Showing 5 of 5
withdrawnphase_2

Parkinson's Disease With Mild Cognitive Impairment Treated With Nicotinic Agonist Drug

NCT04810104
completedphase_1

Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD0328 in Elderly Healthy Subjects

NCT00687141
terminatedphase_2

Study to Asses Pharmacodynamics, Pharmacokinetics, Safety and Tolerability of AZD0328 in Patients With Schizophrenia

NCT00669903
completedphase_1

To Evaluate the Effect of Food on the Pharmacokinetics (PK) of AZD0328

NCT00752830
completedphase_1

Safety, Tolerability & PK of AZD0328 in Caucasian & Japanese

NCT00738959

Clinical Trials (5)

Showing 5 of 5 trials
NCT04810104Phase 2

Parkinson's Disease With Mild Cognitive Impairment Treated With Nicotinic Agonist Drug

Withdrawn
NCT00687141Phase 1

Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD0328 in Elderly Healthy Subjects

Completed
NCT00669903Phase 2

Study to Asses Pharmacodynamics, Pharmacokinetics, Safety and Tolerability of AZD0328 in Patients With Schizophrenia

Terminated
NCT00752830Phase 1

To Evaluate the Effect of Food on the Pharmacokinetics (PK) of AZD0328

Completed
NCT00738959Phase 1

Safety, Tolerability & PK of AZD0328 in Caucasian & Japanese

Completed

All 5 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
5